Los Angeles, CA, United States of America

Brett Eugene Lomenick

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Brett Eugene Lomenick

Introduction

Brett Eugene Lomenick is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating age-related diseases. With a total of 4 patents to his name, Lomenick's work is paving the way for advancements in medical treatments.

Latest Patents

Lomenick's latest patents include innovative prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-ketoisohexanoate. These compounds are designed to treat or prevent age-related diseases, disorders, or conditions. The present disclosure provides compounds of Formula (VIA), Formula (IIIA), Formula (IVA), and Formula (VA). Additionally, he has developed ketobutyrate compounds and compositions that focus on treating, inhibiting, or reducing aging in subjects. These methods aim to enhance the lifespan of individuals through the administration of these compounds.

Career Highlights

Lomenick is affiliated with the University of California, where he conducts research and develops his innovative ideas. His work has garnered attention for its potential impact on health and longevity.

Collaborations

Some of his notable coworkers include Jing Huang and Rui Hao, who contribute to the collaborative efforts in research and development within the university.

Conclusion

Brett Eugene Lomenick's contributions to the field of pharmaceuticals through his innovative patents highlight the importance of research in combating age-related diseases. His work continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…